Lecture 4b: Mechanisms of Oncogenic Viruses Flashcards
Anchorage-independent growth
The ability of cells to proliferate while held in suspension.
Nude strain mice
Mice lacking a thymus and are incredibly immunocompromised and are therefore highly receptive to engradted cells
Two direct mechanisms for viral oncogenes
- Viral oncogenes
- Insertional mutagenesis
Viral oncogenes
Viruses that carry an oncogene termed the “Viral oncogene” that overstimulates the normal host pathways that promote abnormal cell proliferation.
Insertional mutagenesis
Viral trans-activating genes activate the expression of proto-oncogenes or inactivate tumor suppressor genes
Indirect mechanisms of viral-induced oncogenesis.
Modulation of host immune responses by oncogenic viruses.
-Cause chronic inflammation that can lead to oncogenic transformation
-Reduce immune activity
Origin of viral oncogenes
Retroviruses can acquire and transduce cellular genes
Origin of viral SRC oncogene
ALV lacks viral oncogene and will “Kidnap” it via transduction of c-src gene. Cellular transformation results in excessive phosphorylation of cellular proteins by pp60v-src and the deletion of v-src abolishes the tumorigenic potential of SRV. The product c-SRC is over expressed and highly active
Difference between human c-SRC, chicken c-SRC. and chicken v-SRC.
-Chicken v-Src lacks carboxy-terminal negative regulatory domain and contains 12 carboxy-substituted amino acids and numerous point mutations which cause high activity in this protein.
Functions of Src C-terminal domain
Negative regulatory and tyrosine inhibitory function
Two viral oncoproteins that mediate the induction of neoplasia by HPV.
E6 and E7
Continued expression of high-risk HPV E6 and E7
Causes inactivation of the retinoblastoma pRB and p53 tumor suppressor pathways.
Viral factor HBx
Key regulatory factor of the hepatitis B virus and the main etiology for HBV associated liver diseases such as cirrhosis and hepatocellular carcinoma (HCC)
Consequences of chronic HBV and HCV infections
Stimulates an immune response that kills hepatocytes followed by liver regeneration. If the infection isn’t cleared the damage and regeneration cycles occur repeatedly which promotes accumulation of oncogenic mutations and epigenetic changes that lead to tumorigenesis.
Expression of human T-cell leukemia virus type 1 (Tax oncoprotein)
Induces DNA damage as reflected in a significant increase of micronuclei in cells.